KLOTHO allele status and the risk of early-onset occult coronary artery disease.

We previously identified a functional variant of KLOTHO (termed "KL-VS"), which harbors two amino acid substitutions in complete linkage disequilibrium and is associated with reduced human longevity when in homozygosity. Klotho-deficient mice display extensive arteriosclerosis when fed a normal diet, suggesting a potent genetic predisposition. To determine whether klotho influences atherosclerotic risk in humans, we performed cross-sectional studies to assess the association between the KL-VS allele and occult coronary artery disease (CAD) in two independent samples of apparently healthy siblings of individuals with early-onset (age <60 years) CAD (SIBS-I [N=520] and SIBS-II [N=436]). Occult CAD was defined as the occurrence of a reversible perfusion defect during exercise thallium scintigraphy and/or as an abnormal result of an exercise electrocardiogram (SIBS-I, n=97; SIBS-II, n=56). In SIBS-I, the KL-VS allele conferred a relative odds of 1.90 (95% confidence interval 1.21-2.98) for occult CAD, after adjusting for familial intraclass correlations (P<.005). Logistic regression modeling, incorporating known CAD risk factors, demonstrated that the KL-VS allele is an independent risk factor (P<.019) and that the imposed risk of KL-VS allele status is influenced by modifiable risk factors. Hypertension (P<.022) and increasing high-density lipoprotein cholesterol (HDL-C) levels (P<.022) mask or reduce the risk conferred by the KL-VS allele, respectively, whereas current smoking (P<.004) increases the risk. Remarkably concordant effects of the KL-VS allele and modifying factors on the risk of occult CAD were seen in SIBS-II. These results demonstrate that the KL-VS allele is an independent risk factor for occult CAD in two independent high-risk samples. Modifiable risk factors, including hypertension, smoking status, and HDL-C level, appear to influence the risk imposed by this allele.

[1]  R. Karas,et al.  A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. , 2002, American heart journal.

[2]  Toru Suzuki,et al.  Regulation of angiogenesis by the aging suppressor gene klotho. , 2002, Biochemical and biophysical research communications.

[3]  H. Gavras,et al.  Angiotensin II as a cardiovascular risk factor , 2002, Journal of Human Hypertension.

[4]  M. Nangaku,et al.  In Vivo klotho Gene Transfer Ameliorates Angiotensin II-Induced Renal Damage , 2002, Hypertension.

[5]  I. Mian,et al.  Association of human aging with a functional variant of klotho , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Richard G. W. Anderson,et al.  High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase , 2001, Nature Medicine.

[7]  L. Iacoviello,et al.  [Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[8]  H. Brunner Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. , 2001, The American journal of cardiology.

[9]  B. Adams-Huet,et al.  Individual cholesterol variation in response to a margarine- or butter-based diet: A study in families. , 2000, JAMA.

[10]  R. Nagai,et al.  In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. , 2000, Biochemical and biophysical research communications.

[11]  M. Noda,et al.  Improvement of multiple pathophysiological phenotypes of klotho (kl/kl) mice by adenovirus‐mediated expression of the klotho gene , 2000, The journal of gene medicine.

[12]  R. Nagai,et al.  Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases , 2000, Cellular and Molecular Life Sciences CMLS.

[13]  S. Humphries,et al.  Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers. , 2000, Atherosclerosis.

[14]  L. Clark,et al.  Primary prevention of cardiovascular disease in high-risk patients: physiologic and demographic risk factor differences between African American and white American populations. , 1999, The American journal of medicine.

[15]  R. Klesges,et al.  A study of the psychometric and predictive properties of the Fagerström Test for Nicotine Dependence in a population of young smokers. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[16]  J. Ordovás,et al.  The genetics of serum lipid responsiveness to dietary interventions , 1999, Proceedings of the Nutrition Society.

[17]  L. Becker,et al.  Markedly high prevalence of coronary risk factors in apparently healthy African-American and white siblings of persons with premature coronary heart disease. , 1998, The American journal of cardiology.

[18]  R. Nagai,et al.  Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. , 1998, Biochemical and biophysical research communications.

[19]  R. Nagai,et al.  Klotho protein protects against endothelial dysfunction. , 1998, Biochemical and biophysical research communications.

[20]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[21]  J. Coresh,et al.  Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population. , 1996, Circulation.

[22]  R. Weinberg,et al.  Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. , 1994, The New England journal of medicine.

[23]  B. Morgenstern,et al.  Human blood pressure determination by sphygmomanometry. , 1993, Circulation.

[24]  W. Kannel,et al.  Coronary risk associated with age and sex of parental heart disease in the Framingham Study. , 1989, The American journal of cardiology.

[25]  L. Becker,et al.  Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis. , 1989, Journal of the American College of Cardiology.

[26]  S Shea,et al.  Family history as an independent risk factor for coronary artery disease. , 1984, Journal of the American College of Cardiology.

[27]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[28]  M. Mayo,et al.  Smoking in urban African Americans: behaviors, gender differences, and motivation to quit. , 2001, Ethnicity & disease.

[29]  M. Bernstein,et al.  Validation of self-reported smoking status by simultaneous measurement of carbon monoxide and salivary thiocyanate. , 2001, Preventive medicine.

[30]  K. Ahijevych Nicotine metabolism variability and nicotine addiction. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[31]  S L Zeger,et al.  Regression analysis for correlated data. , 1993, Annual review of public health.